These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 22230258)
1. Targeted therapies in the treatment of germ cell tumors: the need for new approaches against "orphan" tumors. Sánchez-Muñoz A; Jiménez-Rodríguez B; Navarro-Pérez V; Medina-Rodríguez L; Llácer C; Vicioso L; Machuca J; Alba E Crit Rev Oncol Hematol; 2012 Sep; 83(3):444-51. PubMed ID: 22230258 [TBL] [Abstract][Full Text] [Related]
2. New biologic agents for the treatment of gynecologic cancers. Horowitz N; Matulonis UA Hematol Oncol Clin North Am; 2012 Feb; 26(1):133-56. PubMed ID: 22244666 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy and targeted agents for thymic malignancies. Girard N Expert Rev Anticancer Ther; 2012 May; 12(5):685-95. PubMed ID: 22594902 [TBL] [Abstract][Full Text] [Related]
4. Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer. Kollmannsberger C; Mayer F; Pressler H; Koch S; Kanz L; Oosterhuis JW; Looijenga LH; Bokemeyer C Cancer; 2002 Jul; 95(2):301-8. PubMed ID: 12124830 [TBL] [Abstract][Full Text] [Related]
5. Targeted therapies for patients with germ cell tumors. Fenner MH; Beutel G; Grünwald V Expert Opin Investig Drugs; 2008 Apr; 17(4):511-22. PubMed ID: 18363516 [TBL] [Abstract][Full Text] [Related]
6. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors. Newton HB Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572 [TBL] [Abstract][Full Text] [Related]
7. The paradox of triple negative breast cancer: novel approaches to treatment. Fornier M; Fumoleau P Breast J; 2012; 18(1):41-51. PubMed ID: 22098334 [TBL] [Abstract][Full Text] [Related]
13. C-kit as a target in the treatment of acute myelogenous leukemia. Advani AS Curr Hematol Rep; 2005 Jan; 4(1):51-8. PubMed ID: 15610660 [TBL] [Abstract][Full Text] [Related]
14. [New drugs and targeted therapeutic agents in ovarian cancer]. de La Motte Rouge T; Petrella MC; Michels J; Even C; Balleyguier C; Duclos J; Mazeron R; Morice P; Pautier P; Lhommé C Bull Cancer; 2009 Dec; 96(12):1215-24. PubMed ID: 19919916 [TBL] [Abstract][Full Text] [Related]
15. Investigational targeted therapies for the treatment of testicular germ cell tumors. Oing C; Kollmannsberger C; Oechsle K; Bokemeyer C Expert Opin Investig Drugs; 2016 Sep; 25(9):1033-43. PubMed ID: 27286362 [TBL] [Abstract][Full Text] [Related]
16. Array-based pharmacogenomics of molecular-targeted therapies in oncology. Sanoudou D; Mountzios G; Arvanitis DA; Pectasides D Pharmacogenomics J; 2012 Jun; 12(3):185-96. PubMed ID: 22249357 [TBL] [Abstract][Full Text] [Related]
17. Targeted therapy of hepatocellular carcinoma: present and future. Chan SL; Yeo W J Gastroenterol Hepatol; 2012 May; 27(5):862-72. PubMed ID: 22369685 [TBL] [Abstract][Full Text] [Related]
18. Small molecule inhibitors in children with malignant gliomas. Herrington B; Kieran MW Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732 [TBL] [Abstract][Full Text] [Related]
19. Progress in cancer chemotherapy with special stress on molecular-targeted therapy. Saijo N Jpn J Clin Oncol; 2010 Sep; 40(9):855-62. PubMed ID: 20651047 [TBL] [Abstract][Full Text] [Related]